TAFA3
gene geneOn this page
Also known as TAFA-3
Summary
TAFA3 (TAFA chemokine like family member 3, HGNC:21590) is a protein-coding gene on chromosome 1p13.2, encoding Chemokine-like protein TAFA-3 (Q7Z5A8). Plays a role in the regulation of microglia polarization.
This gene is a member of the TAFA family which is composed of five highly homologous genes that encode small secreted proteins. These proteins contain conserved cysteine residues at fixed positions, and are distantly related to MIP-1alpha, a member of the CC-chemokine family. The TAFA proteins are predominantly expressed in specific regions of the brain, and are postulated to function as brain-specific chemokines or neurokines, that act as regulators of immune and nervous cells. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Source: NCBI Gene 284467 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_182759
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21590 |
| Approved symbol | TAFA3 |
| Name | TAFA chemokine like family member 3 |
| Location | 1p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TAFA-3 |
| Ensembl gene | ENSG00000184599 |
| Ensembl biotype | protein_coding |
| OMIM | 617497 |
| Entrez | 284467 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000361886, ENST00000369630
RefSeq mRNA: 2 — MANE Select: NM_182759
NM_001004440, NM_182759
CCDS: CCDS30806, CCDS856
Canonical transcript exons
ENST00000361886 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001315682 | 112723016 | 112723165 |
| ENSE00001331903 | 112722233 | 112722348 |
| ENSE00001435893 | 112724013 | 112724137 |
| ENSE00001865267 | 112720577 | 112720634 |
| ENSE00003475063 | 112726629 | 112727235 |
| ENSE00003920834 | 112718905 | 112719299 |
Expression profiles
Bgee: expression breadth broad, 83 present calls, max score 72.39.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1870 / max 42.6393, expressed in 56 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4704 | 0.0894 | 25 |
| 201621 | 0.0818 | 20 |
| 4703 | 0.0158 | 5 |
Top tissues by expression
115 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 72.39 | gold quality |
| right testis | UBERON:0004534 | 72.14 | gold quality |
| testis | UBERON:0000473 | 72.05 | gold quality |
| thymus | UBERON:0002370 | 71.67 | silver quality |
| cerebellar vermis | UBERON:0004720 | 70.30 | gold quality |
| cerebellum | UBERON:0002037 | 68.65 | gold quality |
| cerebellar cortex | UBERON:0002129 | 68.60 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 68.50 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.38 | gold quality |
| quadriceps femoris | UBERON:0001377 | 64.14 | gold quality |
| substantia nigra | UBERON:0002038 | 62.24 | gold quality |
| spinal cord | UBERON:0002240 | 58.39 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 58.34 | gold quality |
| primary visual cortex | UBERON:0002436 | 54.77 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.32 | gold quality |
| right adrenal gland | UBERON:0001233 | 53.97 | gold quality |
| frontal cortex | UBERON:0001870 | 52.56 | gold quality |
| right ovary | UBERON:0002118 | 51.25 | gold quality |
| hypothalamus | UBERON:0001898 | 51.17 | gold quality |
| adrenal gland | UBERON:0002369 | 50.52 | gold quality |
| right frontal lobe | UBERON:0002810 | 50.27 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 50.24 | gold quality |
| cerebral cortex | UBERON:0000956 | 50.12 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 50.12 | gold quality |
| brain | UBERON:0000955 | 49.74 | gold quality |
| amygdala | UBERON:0001876 | 49.53 | gold quality |
| temporal lobe | UBERON:0001871 | 49.24 | gold quality |
| ovary | UBERON:0000992 | 49.18 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 49.00 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 48.70 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 31.61 |
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting TAFA3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-4527 | 99.66 | 67.43 | 714 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-4686 | 98.77 | 66.87 | 964 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-93-3P | 98.15 | 66.65 | 1309 |
| HSA-MIR-4632-5P | 97.82 | 65.38 | 1470 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-4667-5P | 97.61 | 66.67 | 1683 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
| HSA-MIR-663B | 97.40 | 62.91 | 664 |
| HSA-MIR-331-5P | 96.59 | 67.94 | 705 |
| HSA-MIR-7108-5P | 96.42 | 66.17 | 598 |
Literature-anchored findings (GeneRIF, showing 1)
- FAM19A3 modulates the microglia/macrophage polarization dynamics and ameliorates cerebral ischemia. (PMID:25595455)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tafa3b | ENSDARG00000020292 |
| danio_rerio | tafa4b | ENSDARG00000062471 |
| danio_rerio | tafa3a | ENSDARG00000079446 |
| mus_musculus | Tafa3 | ENSMUSG00000055865 |
| rattus_norvegicus | Tafa3 | ENSRNOG00000030253 |
Paralogs (3): TAFA4 (ENSG00000163377), TAFA1 (ENSG00000183662), TAFA2 (ENSG00000198673)
Protein
Protein identifiers
Chemokine-like protein TAFA-3 — Q7Z5A8 (reviewed: Q7Z5A8)
All UniProt accessions (1): Q7Z5A8
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the regulation of microglia polarization.
Subcellular location. Secreted.
Tissue specificity. Brain-specific.
Similarity. Belongs to the TAFA family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z5A8-1 | 1, TAFA3 | yes |
| Q7Z5A8-2 | 2, TAFA3.2 |
RefSeq proteins (2): NP_001004440, NP_877436* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020350 | Chemokine-like_TAFA | Family |
| IPR051743 | TAFA_chemokine-like | Family |
Pfam: PF12020
UniProt features (3 total): signal peptide 1, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z5A8-F1 | 87.45 | 0.66 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 102 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION, GOBP_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_MYELOID_LEUKOCYTE_ACTIVATION, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION, GOBP_MACROPHAGE_ACTIVATION, GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE, GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE
GO Biological Process (3): negative regulation of microglial cell activation (GO:1903979), positive regulation of microglial cell activation (GO:1903980), signal transduction (GO:0007165)
GO Molecular Function (1): receptor ligand activity (GO:0048018)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microglial cell activation | 2 |
| regulation of microglial cell activation | 2 |
| negative regulation of macrophage activation | 1 |
| negative regulation of neuroinflammatory response | 1 |
| positive regulation of macrophage activation | 1 |
| positive regulation of neuroinflammatory response | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| signaling receptor binding | 1 |
| signal transduction | 1 |
| signaling receptor activator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
398 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAFA3 | KRTAP19-5 | Q3LI72 | 578 |
| TAFA3 | TSNAX | Q99598 | 460 |
| TAFA3 | NT5DC3 | Q86UY8 | 434 |
| TAFA3 | GUCY1A1 | Q02108 | 422 |
| TAFA3 | PRR30 | Q53SZ7 | 417 |
| TAFA3 | NCLN | Q969V3 | 400 |
| TAFA3 | FAXDC2 | Q96IV6 | 373 |
| TAFA3 | KBTBD12 | Q3ZCT8 | 337 |
| TAFA3 | LZTS3 | O60299 | 333 |
| TAFA3 | CCDC171 | Q6TFL3 | 324 |
| TAFA3 | TMEM215 | Q68D42 | 314 |
| TAFA3 | ARPP21 | Q9UBL0 | 310 |
| TAFA3 | GLRA1 | P23415 | 307 |
| TAFA3 | ARL15 | Q9NXU5 | 307 |
| TAFA3 | LRRTM2 | O43300 | 295 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | TAFA3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TAFA3 | FUOM | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (141): FLAD1 (Affinity Capture-MS), DHPS (Affinity Capture-MS), FUOM (Affinity Capture-MS), MAPK9 (Affinity Capture-MS), PPP2R2D (Affinity Capture-MS), THNSL1 (Affinity Capture-MS), JMJD4 (Affinity Capture-MS), PRMT7 (Affinity Capture-MS), C17orf70 (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), LRP1B (Affinity Capture-MS), PBK (Affinity Capture-MS), KDM1B (Affinity Capture-MS), CRYZL1 (Affinity Capture-MS), NHLRC2 (Affinity Capture-MS)
ESM2 similar proteins: A0A291NVT7, A0A4Y5X186, A0A4Y5X1A7, B0VXV3, B0VXV4, O42493, O43278, P01060, P05486, P08163, P0DN42, P0DN43, P0DTJ2, P0DTJ3, P16229, P17668, P48250, P56688, P58990, P67862, Q00945, Q07662, Q07663, Q08E66, Q23247, Q2XXR7, Q2XXR8, Q330K6, Q4R128, Q56R10, Q56R11, Q58T08, Q7M428, Q7TPG5, Q7TPG6, Q7TPG7, Q7TPG8, Q7TQN3, Q7Z5A8, Q7Z5A9
Diamond homologs: M0R7X9, Q3ZBS2, Q5R6N2, Q7TPG5, Q7TPG6, Q7TPG7, Q7TPG8, Q7Z5A7, Q7Z5A8, Q7Z5A9, Q8N3H0, Q91WE9, Q96LR4, Q9N0D3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
939 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:112722357:G:GT | donor_gain | 1.0000 |
| 1:112720630:AAAAG:A | donor_gain | 0.9900 |
| 1:112720631:AAAG:A | donor_gain | 0.9900 |
| 1:112720631:AAAGG:A | donor_loss | 0.9900 |
| 1:112720632:AAG:A | donor_gain | 0.9900 |
| 1:112720632:AAGG:A | donor_loss | 0.9900 |
| 1:112720633:AG:A | donor_gain | 0.9900 |
| 1:112720634:GG:G | donor_gain | 0.9900 |
| 1:112720635:G:GG | donor_gain | 0.9900 |
| 1:112720635:GTAA:G | donor_loss | 0.9900 |
| 1:112721941:GA:G | donor_gain | 0.9900 |
| 1:112721943:G:GG | donor_gain | 0.9900 |
| 1:112721949:G:GG | donor_gain | 0.9900 |
| 1:112722362:G:GA | donor_gain | 0.9900 |
| 1:112723014:A:AG | acceptor_gain | 0.9900 |
| 1:112723014:AGT:A | acceptor_gain | 0.9900 |
| 1:112723015:G:GA | acceptor_gain | 0.9900 |
| 1:112723015:GT:G | acceptor_gain | 0.9900 |
| 1:112723015:GTG:G | acceptor_gain | 0.9900 |
| 1:112723015:GTGC:G | acceptor_gain | 0.9900 |
| 1:112723162:GACG:G | donor_gain | 0.9900 |
| 1:112723166:G:GC | donor_loss | 0.9900 |
| 1:112723166:G:GG | donor_gain | 0.9900 |
| 1:112723167:TGAG:T | donor_loss | 0.9900 |
| 1:112723168:GAGT:G | donor_loss | 0.9900 |
| 1:112726627:A:C | acceptor_loss | 0.9900 |
| 1:112721946:GGA:G | donor_gain | 0.9800 |
| 1:112721947:GAG:G | donor_gain | 0.9800 |
| 1:112722231:AG:A | acceptor_gain | 0.9800 |
| 1:112722232:GG:G | acceptor_gain | 0.9800 |
AlphaMissense
849 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:112724038:G:C | W97C | 0.999 |
| 1:112724038:G:T | W97C | 0.999 |
| 1:112724101:G:C | W118C | 0.999 |
| 1:112724101:G:T | W118C | 0.999 |
| 1:112724099:T:A | W118R | 0.995 |
| 1:112724099:T:C | W118R | 0.995 |
| 1:112723105:T:A | C69S | 0.993 |
| 1:112723106:G:C | C69S | 0.993 |
| 1:112724072:T:A | C109S | 0.993 |
| 1:112724073:G:C | C109S | 0.993 |
| 1:112723156:T:A | C86S | 0.992 |
| 1:112723157:G:C | C86S | 0.992 |
| 1:112724039:T:A | C98S | 0.992 |
| 1:112724040:G:C | C98S | 0.992 |
| 1:112723113:T:G | C71W | 0.989 |
| 1:112724036:T:A | W97R | 0.989 |
| 1:112724036:T:C | W97R | 0.989 |
| 1:112723105:T:C | C69R | 0.988 |
| 1:112724097:G:A | G117E | 0.987 |
| 1:112724105:T:A | C120S | 0.987 |
| 1:112724106:G:C | C120S | 0.987 |
| 1:112723133:G:A | G78D | 0.986 |
| 1:112724054:T:A | C103S | 0.986 |
| 1:112724055:G:C | C103S | 0.986 |
| 1:112724107:C:G | C120W | 0.986 |
| 1:112723111:T:A | C71S | 0.985 |
| 1:112723112:G:C | C71S | 0.985 |
| 1:112723157:G:A | C86Y | 0.985 |
| 1:112724047:G:A | M100I | 0.985 |
| 1:112724047:G:C | M100I | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000495836 (1:112727205 A>G), RS1000807781 (1:112717122 A>C), RS1001014954 (1:112721569 C>G), RS1001155217 (1:112717298 G>A,C), RS1001804335 (1:112717782 C>T), RS1002020586 (1:112722832 G>A), RS1002109330 (1:112717497 T>C,G), RS1002134502 (1:112722637 G>A,T), RS1002708795 (1:112719069 G>A,T), RS1002810484 (1:112719817 GCC>G), RS1002819315 (1:112725415 A>C), RS1003213851 (1:112719305 T>A), RS1003265990 (1:112724178 C>A,T), RS1004909243 (1:112717365 T>C), RS1005148377 (1:112717240 G>A)
Disease associations
OMIM: gene MIM:617497 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002930_16 | Cobalt levels | 7.000000e-06 |
| GCST010002_392 | Refractive error | 8.000000e-20 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.